Emergent Biosolutions
EBS
EBS
263 hedge funds and large institutions have $2.61B invested in Emergent Biosolutions in 2020 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 87 increasing their positions, 95 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.25% more ownership
Funds ownership: 87.12% → 87.37% (+0.25%)
8% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 95
37% less call options, than puts
Call options by funds: $1.49M | Put options by funds: $2.36M
Holders
263
Holding in Top 10
5
Calls
$1.49M
Puts
$2.36M
Top Buyers
| 1 | +$43.3M | |
| 2 | +$17.6M | |
| 3 | +$16.6M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$15.3M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$9.36M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$16.2M | |
| 3 | -$15.5M | |
| 4 |
BlackRock
New York
|
-$9.96M |
| 5 |
Lazard Asset Management
New York
|
-$9.51M |